Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study ...

FibroMAP combines the power of high-resolution, single-fiber, and spatially resolved datasets generated by PharmaNest's digital pathology and image analysis platform (FibroNest) with advanced ...

making obtaining high-resolution transcriptomic profiles across large tissue areas challenging. Predicting ST from H&E-stained histology images has emerged as a promising alternative to address these ...

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

GUARDANT HEALTH LAUNCHES GUARDANT360 TISSUE, FIRST TISSUE MOLECULAR PROFILING TEST WITH COMPREHENSIVE MULTIOMIC ANALYSIS TO PROVIDE A MORE COMPLETE VIEW OF CANCER Powered by Guardant Infinity ...

The new test allows for the analysis of tissue samples with 40% fewer tissue slides, enabling the testing of more patients with less tissue. Guardant360 Tissue’s capabilities include analyzing ...

All three foundation models work by converting a high-resolution digital image of a tissue pathology slide into small image tiles, extracting meaningful features from the tiles, and analyzing ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...